Morgan Stanley
BFRI icon

Morgan Stanley’s Biofrontera BFRI Stock Holding History

Morgan Stanley’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-160
Closed -$128 – 8112
2025
Q1 		$128 Buy
+160
New +$165 ﹤0.01% 7528
2024
Q3 		– Sell
-6
Closed -$5 – 7936
2024
Q2 		$5 Buy
+6
New +$8 ﹤0.01% 7807
2024
Q1 		– Sell
-400
Closed -$1.11K – 7834
2023
Q4 		$1.11K Buy
+400
New +$1.75K ﹤0.01% 7191
2022
Q4 		– Sell
-1
Closed – – 7893
2022
Q3 		$0 Buy
+1
New +$27 ﹤0.01% 7703
2022
Q1 		– Hold
0
– – – 7958
2021
Q4 		– Hold
0
– – – 7976

Other funds holding BFRI

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley's BFRI Position: Q2 2025 in Review

Morgan Stanley sold out of Biofrontera (BFRI) in Q2 2025, closing a stake of 160 shares — an estimated $128 sold.

Morgan Stanley first reported a position in BFRI in Q3 2022 and held it in 4 quarters. The position peaked at $1.11K in Q4 2023. 10 funds tracked by Wall St. Rank hold BFRI as of Q2 2025.

  • Morgan Stanley reported no remaining Biofrontera position as of Q2 2025 after selling out during the quarter.
  • Morgan Stanley sold 160 Biofrontera shares in Q2 2025, an estimated $128.
  • Morgan Stanley first reported a position in Biofrontera in Q3 2022 and held it in 4 quarters.
  • Morgan Stanley's Biofrontera position peaked at $1.11K in Q4 2023.
  • 10 funds tracked by Wall St. Rank held Biofrontera as of Q2 2025.

Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.